FDA Adverse Event Injury Summary report: N

QUADROX-ID

MDR report key: 4203036 · Received October 23, 2014

Report

Report Number
8010762-2014-00824
Event Type
Injury
Date Received
October 23, 2014
Date of Event
September 24, 2014
Report Date
September 25, 2014
Manufacturer
MAQUET CARDIOPULMONARY AG
Product Code
DTZ
PMA / PMN Number
K101153
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

MAQUET CARDIOPULMONARY IS AWARE OF SIMILAR COMPLAINTS. THE DEVICES DISPLAYED A SIMILAR MALFUNCTION WHICH WERE TESTED AND EVALUATED UNDER AN OPTICAL MICROSCOPE. DELAMINATION OF SOME GAS FIBERS WAS OBSERVED WHICH ALLOWED FOR THE PRIMING SOLUTION OR BLOOD TO FLOW INSIDE THE GAP BETWEEN THE GAS FIBERS AND POLYURETHANE. GRAVITY THEN ALLOWED FOR PASSAGE TO THE GAS EXITING PATH ALONG THE HOUSING. THE MOST PROBABLE ROOT-CAUSE IS THE DELAMINATION OF THE HOLLOW GAS FIBERS FROM THE POLYURETHANE POTTING AREA. A REVIEW OF THE QUALITY CONTROL PROCESS CONFIRMS THAT 100% FUNCTIONAL INSPECTION FOR LEAKAGE IS PERFORMED DURING PRODUCTION. MAQUET CARDIOPULMONARY (B)(4)HAS INITIATED AN INTERNAL PROCESS (CAPA-(B)(4)) TO ADDRESS THE APPROPRIATE CORRECTIVE AND PREVENTIVE ACTION. THE DEVICE HAS BEEN RETURNED TO MAQUET CARDIOPULMONARY (B)(4), BUT HAS NOT YET BEEN EVALUATED. A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED WHEN NEW INFORMATION BECOMES AVAILABLE. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT A FEW HOURS AFTER VENO-ARTERIAL ECLS (EXTRA CORPOREAL LIFE SUPPORT) THERAPY WAS INITIATED, THE DEVICE LEAKED WHAT APPEARED TO BE PURE BLOOD. THE FLOW RATE WAS 600CC/MINUTE THROUGH THE DEVICE. ANOTHER DEVICE WAS PRIMED AND USED. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
674891 QUADROX-ID OXYGENATOR, CARDIOPULMONARY BYPASS DTZ MAQUET CARDIOPULMONARY AG HMOD 700000-USA 70099667

Patients

Seq Age Sex Outcome Treatment
1 NEWBORN Required Intervention